| 2022-07-28 6:54:8 am |
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders |
BusinessWire |
| Jul-12-22 01:35PM |
Biotech M&A returns as Vertex, Innoviva make buys |
American City Business Journals |
| Jul-11-22 05:07PM |
How this Peninsula company is turning lung drug royalties into acquisitions |
American City Business Journals |
| Jul-11-22 08:14AM |
Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal |
Benzinga |
| Jul-11-22 07:32AM |
Innoviva to Acquire La Jolla Pharmaceutical Company |
Business Wire |
| May-16-22 04:15PM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress |
Business Wire |
| May-16-22 08:45AM |
AcelRx Pharmaceuticals (ACRX) Reports Q1 Loss, Lags Revenue Estimates |
Zacks |
| May-12-22 05:35PM |
Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Tops Revenue Estimates |
Zacks |
| May-05-22 05:35PM |
Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates |
Zacks |
| Apr-28-22 11:28AM |
The past five years for La Jolla Pharmaceutical (NASDAQ:LJPC) investors has not been profitable |
Simply Wall St. |
| Mar-09-22 08:15AM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Corporate Progress |
Business Wire |
| Jan-24-22 07:05AM |
What Kind Of Shareholders Own La Jolla Pharmaceutical Company (NASDAQ:LJPC)? |
Simply Wall St. |
| Jan-18-22 01:38PM |
HealthInvest Partners AB Buys McKesson Corp, Cardinal Health Inc, AmerisourceBergen Corp, Sells ... |
GuruFocus.com |
| Nov-17-21 08:00AM |
La Jolla Pharmaceutical Company Announces Share Repurchase Plan |
Business Wire |
| Nov-04-21 10:05AM |
La Jolla Pharmaceutical (LJPC) Reports Q3 Loss, Tops Revenue Estimates |
Zacks |
| Nov-04-21 08:45AM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate Progress |
Business Wire |
| Nov-01-21 03:01PM |
La Jolla Pharmaceutical (LJPC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release |
Zacks |
| Oct-25-21 10:46AM |
La Jolla Pharmaceutical (NASDAQ:LJPC) shareholders have endured a 79% loss from investing in the stock five years ago |
Simply Wall St. |
| Oct-04-21 12:51AM |
Is La Jolla Pharmaceutical Company (LJPC) Going to Burn These Hedge Funds? |
Insider Monkey |
| Sep-10-21 08:00AM |
Tony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical Company |
Business Wire |
| Aug-05-21 10:15AM |
La Jolla Pharmaceutical (LJPC) Tops Q2 Earnings and Revenue Estimates |
Zacks |
| Aug-05-21 08:30AM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress |
Business Wire |
| Jul-29-21 03:05PM |
Will La Jolla Pharmaceutical (LJPC) Report Negative Q2 Earnings? What You Should Know |
Zacks |
| Jul-26-21 05:01AM |
La Jolla Pharmaceutical Company (NASDAQ:LJPC) Has Found A Path To Profitability |
Simply Wall St. |
| Jun-10-21 04:57AM |
What You Need To Know About La Jolla Pharmaceutical Company's (NASDAQ:LJPC) Investor Composition |
Simply Wall St. |
| May-18-21 06:22AM |
Moving Average Crossover Alert: La Jolla Pharmaceutical (LJPC) |
Zacks |
| May-07-21 10:05AM |
La Jolla Pharmaceutical (LJPC) Misses Q1 Earnings Estimates |
Zacks |
| May-07-21 08:45AM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Corporate Progress |
Business Wire |
| Mar-11-21 03:12AM |
La Jolla Pharmaceutical Company (NASDAQ:LJPC) Insiders Increased Their Holdings |
Simply Wall St. |
| Mar-08-21 10:45AM |
La Jolla Pharmaceutical (LJPC) Reports Q4 Loss, Tops Revenue Estimates |
Zacks |
| Mar-08-21 08:55AM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Corporate Progress |
Business Wire |
| Jan-16-21 01:41AM |
Growth Investors: Industry Analysts Just Upgraded Their La Jolla Pharmaceutical Company (NASDAQ:LJPC) Revenue Forecasts By 18% |
Simply Wall St. |
| Jan-12-21 08:15AM |
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue |
Benzinga |
| Jan-12-21 07:00AM |
La Jolla Pharmaceutical Company Announces Exclusive Licensing Agreement for GIAPREZA (Angiotensin II) and XERAVA (Eravacycline) in Europe |
Business Wire |
| Dec-28-20 03:08AM |
What You Need To Know About La Jolla Pharmaceutical Company's (NASDAQ:LJPC) Investor Composition |
Simply Wall St. |
| Dec-23-20 08:56AM |
La Jolla Pharma (LJPC) Sees Hammer Chart Pattern: Time to Buy? |
Zacks |
| Dec-02-20 10:15PM |
Do Hedge Funds Love La Jolla Pharmaceutical Company (LJPC)? |
Insider Monkey |
| Nov-13-20 07:07AM |
US$10.67: That's What Analysts Think La Jolla Pharmaceutical Company (NASDAQ:LJPC) Is Worth After Its Latest Results |
Simply Wall St. |
| Nov-09-20 05:35PM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2020 |
Business Wire |
| Oct-19-20 03:30PM |
These 3 Penny Stocks Have Massive Upside Potential, Says Cowen |
TipRanks |
| Oct-09-20 10:49AM |
Breakeven On The Horizon For La Jolla Pharmaceutical Company (NASDAQ:LJPC) |
Simply Wall St. |
| Aug-25-20 08:31AM |
Independent Director David Ramsay Just Bought A Handful Of Shares In La Jolla Pharmaceutical Company (NASDAQ:LJPC) |
Simply Wall St. |
| Aug-21-20 02:02PM |
La Jolla Pharmaceutical (NASDAQ:LJPC) Share Prices Have Dropped 87% In The Last Five Years |
Simply Wall St. |
| Aug-06-20 08:30AM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2020 and Highlights Recent Corporate Progress |
GlobeNewswire |
| Jul-28-20 04:16PM |
Larry Edwards Appointed President and Chief Executive Officer of La Jolla Pharmaceutical Company |
GlobeNewswire |
| Jul-28-20 04:15PM |
La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc. |
GlobeNewswire |
| Jun-24-20 07:30AM |
La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc. |
GlobeNewswire |
| Jun-22-20 12:14PM |
La Jolla Pharmaceutical Rekindles Interest In Tetraphase With Sweetened Offer |
Benzinga |
| Jun-14-20 07:00AM |
4 Biotech Stocks That Are Seeing Big Buys in June |
Barrons.com |
| Jun-10-20 04:22PM |
Is La Jolla Pharmaceutical Company (LJPC) Going to Burn These Hedge Funds? |
Insider Monkey |
| May-21-20 08:30AM |
How La Jolla (LJPC) Stock Stands Out in a Strong Industry |
Zacks |
| May-07-20 12:55PM |
Bidding War Sends Tetraphase Shares Soaring |
Benzinga |
| May-06-20 08:41AM |
La Jolla Pharmaceutical Company (NASDAQ:LJPC) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year |
Simply Wall St. |
| May-04-20 09:55AM |
La Jolla Pharmaceutical (LJPC) Reports Q1 Loss, Lags Revenue Estimates |
Zacks |
| May-04-20 08:30AM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2020 |
GlobeNewswire |
| Apr-27-20 12:31PM |
Will La Jolla Pharmaceutical (LJPC) Report Negative Q1 Earnings? What You Should Know |
Zacks |
| Apr-13-20 08:30AM |
La Jolla Pharmaceutical Company to Provide GIAPREZA (Angiotensin II) for Emergency Medical Program in Patients with Septic Shock Due to COVID-19 at CHIREC Delta Hospital, Brussels, Belgium |
GlobeNewswire |
| Apr-07-20 08:30AM |
La Jolla Pharmaceutical Company to Provide GIAPREZA (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at University Hospital Münster in Germany |
GlobeNewswire |
| Apr-06-20 08:30AM |
La Jolla Pharmaceutical Company to Provide GIAPREZA (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at Royal Surrey County Hospital, Guildford, Surrey, United Kingdom |
GlobeNewswire |
| Apr-03-20 08:30AM |
La Jolla Pharmaceutical Company to Provide GIAPREZA (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at University Hospital Frankfurt in Germany |
GlobeNewswire |
| Apr-02-20 08:30AM |
La Jolla Pharmaceutical Company to Provide GIAPREZA (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at Guys and St. Thomas NHS Foundation Trust, London, United Kingdom |
GlobeNewswire |
| Mar-13-20 08:00AM |
La Jolla Pharmaceutical Company to Provide GIAPREZA (Angiotensin II) in Italy for Compassionate Use in Patients with Septic Shock Associated with COVID-19 |
GlobeNewswire |
| Mar-02-20 09:55AM |
La Jolla Pharmaceutical (LJPC) Reports Q4 Loss, Tops Revenue Estimates |
Zacks |
| Mar-02-20 08:30AM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2019 |
GlobeNewswire |
| Feb-24-20 12:30PM |
La Jolla Pharmaceutical (LJPC) May Report Negative Earnings: Know the Trend Ahead of Q4 Release |
Zacks |
| Jan-27-20 08:23AM |
Will La Jolla Continue to Surge Higher? |
Zacks |
| Jan-18-20 05:09PM |
Notable Insider Buys Last Week: Small-Cap Biotechs |
Benzinga |
| Jan-15-20 07:00AM |
Two Small Biotechs See Big Stock Purchases by Their Largest Holders |
Barrons.com |
| Jan-09-20 08:00AM |
La Jolla Pharmaceutical Company Announces Preliminary GIAPREZA (Angiotensin II) Net Sales for the Three and Twelve Months Ended December 31, 2019 |
GlobeNewswire |
| Dec-13-19 03:07PM |
Is La Jolla Pharmaceutical Company (LJPC) A Good Stock To Buy? |
Insider Monkey |
| Nov-26-19 08:06AM |
The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug |
Benzinga |
| Nov-25-19 09:04AM |
La Jolla shares fall on CEO departure, clinical trial results |
MarketWatch |
| Nov-25-19 08:35AM |
La Jolla to Reassess Continued Development of LJPC-401 Based on Recent Clinical Results |
GlobeNewswire |
| Nov-25-19 08:30AM |
La Jolla Pharmaceutical Company Announces Management Transition |
GlobeNewswire |
| Nov-15-19 09:52AM |
La Jolla Pharmaceutical Company Just Reported And Analysts Have Been Cutting Their Estimates |
Simply Wall St. |
| Nov-12-19 06:35PM |
La Jolla Pharmaceutical (LJPC) Reports Q3 Loss, Misses Revenue Estimates |
Zacks |
| Nov-12-19 04:47PM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2019 and Highlights Recent Corporate Progress |
GlobeNewswire |
| Nov-12-19 12:21PM |
Should You Worry About La Jolla Pharmaceutical Company's (NASDAQ:LJPC) CEO Salary Level? |
Simply Wall St. |
| Nov-11-19 09:59AM |
La Jolla Pharmaceutical Company (LJPC): Hedge Funds In Wait-and-See Mode |
Insider Monkey |
| Oct-16-19 10:32AM |
Will La Jolla Pharmaceutical (LJPC) Report Negative Q3 Earnings? What You Should Know |
Zacks |
| Aug-29-19 09:00AM |
La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA (angiotensin II) |
GlobeNewswire |
| Aug-16-19 02:38PM |
GWU developed a life-saving drug. It just sold some royalty rights in an 8-figure deal. |
American City Business Journals |
| Aug-14-19 03:36PM |
Does La Jolla Pharmaceutical (NASDAQ:LJPC) Have A Healthy Balance Sheet? |
Simply Wall St. |
| Aug-01-19 09:35AM |
La Jolla Pharmaceutical (LJPC) Reports Q2 Loss, Lags Revenue Estimates |
Zacks |
| Aug-01-19 08:00AM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2019 and Highlights Recent Corporate Progress |
GlobeNewswire |
| Jul-30-19 11:53AM |
Can GW Pharmaceuticals (GWPH) Deliver a Beat in Q2 Earnings? |
Zacks |
| Jul-30-19 11:31AM |
CannTrust (CTST) to Report Q2 Earnings: What's in Store? |
Zacks |
| Jul-23-19 09:00AM |
La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118 (Artesunate) for the Treatment of Malaria |
GlobeNewswire |
| Jul-01-19 08:39AM |
La Jolla (LJPC) Secures Positive CHMP Opinion for Giapreza |
Zacks |
| Jun-28-19 06:30AM |
La Jolla Pharmaceutical Company Receives Positive CHMP Opinion for GIAPREZA (angiotensin II) for the Treatment of Refractory Hypotension in Adults with Septic or Other Distributive Shock |
GlobeNewswire |
| Jun-11-19 11:55AM |
Implied Volatility Surging for La Jolla Pharmaceutical (LJPC) Stock Options |
Zacks |
| Jun-07-19 02:02PM |
Here's Why La Jolla Pharmaceutical Has More Than Doubled Over the Last 2 Days |
Motley Fool |
| Jun-06-19 09:00AM |
La Jolla Pharmaceutical Company Announces Positive Results from Pre-Specified Interim Analysis of Phase 2 Study of LJPC-401 in Patients with Hereditary Hemochromatosis |
GlobeNewswire |
| May-22-19 01:49PM |
How La Jolla Pharmaceutical Company (NASDAQ:LJPC) Can Impact Your Portfolio Volatility |
Simply Wall St. |
| May-06-19 06:25PM |
La Jolla Pharmaceutical (LJPC) Reports Q1 Loss, Misses Revenue Estimates |
Zacks |
| May-06-19 05:15PM |
La Jolla Pharmaceutical: 1Q Earnings Snapshot |
Associated Press |
| May-06-19 04:11PM |
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2019 and Highlights Recent Corporate Progress |
GlobeNewswire |
| May-02-19 10:33AM |
La Jolla Pharmaceutical (LJPC) May Report Negative Earnings: Know the Trend Ahead of Q1 Release |
Zacks |
| Apr-29-19 01:25PM |
Consider These 3 Falling Knives |
GuruFocus.com |
| Apr-24-19 09:00AM |
La Jolla Pharmaceutical Company Announces U.S. FDAs Grant of Breakthrough Therapy Designation for LJPC-0118 for the Treatment of Severe Malaria |
GlobeNewswire |
| Mar-11-19 07:30AM |
La Jolla Pharmaceutical Company Appoints Darryl Wellinghoff as Chief Commercial Officer |
GlobeNewswire |